// App-Quantinova.ai

: Estimating the Burden of Hospital-Acquired Venous Thromboembolism: The Argument for Implementation of Mandatory Risk Reduction Strategies

Researchers

Presenter

  • Barry Kevane

Principal Investigators

  • Mary Day

  • Noirin Bannon

  • Leo Lawler

  • Tomas Breslin

  • Claire Andrews

  • Howard Johnson

  • Michael Fitzpatrick

  • Karen Murphy

  • Olivia Mason

  • Sarah Kelliher

  • Annemarie O'Neill

  • Fionnuala Donohue

  • Fionnuala Ni Ainle

Medical Centers

  • Rheumatology, Mater Misericordiae University Hospital, Dublin , Ireland

  • School of Medicine and Medical Science, University College Dublin, Dublin, Ireland

  • IEHG VTE Working Group, Ireland East Hospital Group, Dublin, Ireland

  • Irish Network for Venous Thromboembolism Research (INViTE), Dublin, Ireland

  • Mater Misericordiae University Hospital, University College Dublin, Dublin, Ireland

  • Emergency Medicine, Mater Misericordiae University Hospital, Dublin, Ireland

  • Health Intelligence R & D, Health Service Executive of Ireland, Dublin, Ireland

  • Data Analytics, Ireland East Hospital Group, Dublin, Ireland

  • St Vincent's University Hospital, Dublin, Ireland

  • Centre for Support and Training in Analysis and Research (CSTAR), University College Dublin, Dublin, Ireland

  • Thrombosis Ireland, Dublin, Ireland

  • Mater Misericordiae University Hospital, Mmuh, Ireland

  • Irish Centre for Vascular Biology, RCSI, Dublin, Ireland

Locations

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved